Evidence based medicine, now backed by updated reimbursement.

CMS has issued new ICD-10-PCS codes to report the use of EKOS with a qualifying character value to represent procedures using intravascular ultrasound assisted thrombolysis with tissue plasminogen activator (tPA). This announcement resulted in a reimbursement increase for PE and vascular procedures using EKOS. This new reimbursement means you can make clinical decisions based on evidence, not economics.  

Effective October 1, 2020, EKOS reimbursement is increasing by:

EKOS - Final CMS Hospital Inpatient Reimbursement

IMPORTANT INFORMATION

Health economic and reimbursement information provided by Boston Scientific Corporation is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice. Boston Scientific encourages providers to submit accurate and appropriate claims for services. It is always the provider’s responsibility to determine medical necessity, the proper site for delivery of any services, and to submit appropriate codes, charges, and modifiers for services that are rendered. It is also always the provider’s responsibility to understand and comply with Medicare national coverage determinations (NCD), Medicare local coverage determinations (LCD) and any other coverage requirements established by relevant payers which can be updated frequently. Boston Scientific recommends that you consult with your payers, reimbursement specialists and/or legal counsel regarding coding, coverage, and reimbursement matters. Boston Scientific does not promote the use of its products outside their FDA-approved label.


CPT ©2019 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Restrictions Apply to Government Use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

*Weighted averages based on distribution of MS-DRGs from CMS' Final IPPS FY 2021, MedPAR Vol 7b.
Top